Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $953.70 | Total: $4,768.50 |
| 1 | 10 | $807.84 | Total: $8,078.40 |
| 1 | 25 | $684.42 | Total: $17,110.51 |
| 1 | 50 | $583.44 | Total: $29,172.00 |
| 1 | 100 | $504.90 | Total: $50,490.02 |
Overview
Tigemonam is a monobactam. Tigemonam has potent activity against Gram-negative aerobic bacterial pathogens.
Chemical Properties
| Molecular Formula | C12H15N5O9S2 |
| Molecular Weight | 437.41 |
| CAS Numbers | 102507-71-1 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | N(C(C(=NOCC(O)=O)C=1N=C(N)SC1)=O)[C@H]2C(C)(C)N(OS(=O)(=O)O)C2=O |
Storage and Handling
0C Short Term, -20C Long Term
References
Rylander M, et al. Comparative in-vitro activity of tigemonam, a new monobactam. J Antimicrob Chemother. 1988 Sep;22[3] 307-13.